DE602008005173D1 - Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure - Google Patents

Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure

Info

Publication number
DE602008005173D1
DE602008005173D1 DE602008005173T DE602008005173T DE602008005173D1 DE 602008005173 D1 DE602008005173 D1 DE 602008005173D1 DE 602008005173 T DE602008005173 T DE 602008005173T DE 602008005173 T DE602008005173 T DE 602008005173T DE 602008005173 D1 DE602008005173 D1 DE 602008005173D1
Authority
DE
Germany
Prior art keywords
hyaluronic acid
combination
tamarindic
compositions based
ophthalmic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008005173T
Other languages
German (de)
English (en)
Inventor
Prete Antonio Del
Marco Sanso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RMFA Trading SA
Original Assignee
RMFA Trading SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RMFA Trading SA filed Critical RMFA Trading SA
Publication of DE602008005173D1 publication Critical patent/DE602008005173D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602008005173T 2007-10-02 2008-10-02 Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure Active DE602008005173D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000510A ITRM20070510A1 (it) 2007-10-02 2007-10-02 Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
PCT/IT2008/000626 WO2009044423A1 (en) 2007-10-02 2008-10-02 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid

Publications (1)

Publication Number Publication Date
DE602008005173D1 true DE602008005173D1 (de) 2011-04-07

Family

ID=40314052

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008005173T Active DE602008005173D1 (de) 2007-10-02 2008-10-02 Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure

Country Status (14)

Country Link
US (1) US8455462B2 (enExample)
EP (1) EP2197456B1 (enExample)
JP (1) JP5542674B2 (enExample)
KR (1) KR101570966B1 (enExample)
AT (1) ATE499106T1 (enExample)
CA (1) CA2701721C (enExample)
DE (1) DE602008005173D1 (enExample)
ES (1) ES2361529T3 (enExample)
IT (1) ITRM20070510A1 (enExample)
MX (1) MX2010003488A (enExample)
PL (1) PL2197456T3 (enExample)
PT (1) PT2197456E (enExample)
RU (1) RU2493855C2 (enExample)
WO (1) WO2009044423A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7726809B2 (en) * 2005-02-09 2010-06-01 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
IT1396607B1 (it) * 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
US10206943B2 (en) 2010-05-24 2019-02-19 Indena S.P.A. Antimicrobial compositions
MX342859B (es) 2010-05-24 2016-10-13 Indena Spa Polisacarido de las semillas de tamarindo para usarse en el tratamiento de enfermedades inflamatorias.
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
EP2883931A1 (en) * 2013-12-12 2015-06-17 Omya International AG Improved gel stability
US20170027980A1 (en) 2014-04-15 2017-02-02 Novintethical Pharma Sa Composition based on xyloglucan and proteins for the treatment of intestinal disorders
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
ES2705692T3 (es) 2015-06-11 2019-03-26 Novintethical Pharma Sa Composiciones nasales tópicas que contienen xiloglucanos para usar como descongestionantes
TW201707719A (zh) * 2015-07-13 2017-03-01 國立大學法人東北大學 視神經保護用組成物
AR108280A1 (es) * 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
IT201600108848A1 (it) * 2016-10-27 2018-04-27 Giuliani Spa Composizioni dermatologiche
WO2019025986A1 (en) * 2017-08-02 2019-02-07 Shilpa Medicare Limited OPHTHALMIC COMPOSITIONS OF CYCLOSPORINE
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
US11406658B2 (en) * 2018-07-18 2022-08-09 Atg 20 S.R.L. Composition comprising glycyrrhizin and cosmetic and pharmaceutical uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
IT1283911B1 (it) 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
NZ504108A (en) * 1997-09-26 2002-06-28 Noven Pharma Bioadhesive compositions comprising a polyvinylpyrrolidone polymer and methods for topical administration of active agents
HRP20010309B1 (en) * 1998-12-23 2005-06-30 Idea Ag Improved formulation for topical non-invasive application in vivo
BRPI0414868A (pt) * 2003-10-03 2006-11-28 Allergan Inc composições e métodos compreendendo compostos relacionados com prostaglandina e peptìdios da famìlia do fator trifoliado para o tratamento de glaucoma com hiperemia reduzida
US7726809B2 (en) * 2005-02-09 2010-06-01 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法

Also Published As

Publication number Publication date
KR20100091151A (ko) 2010-08-18
RU2493855C2 (ru) 2013-09-27
EP2197456A1 (en) 2010-06-23
ATE499106T1 (de) 2011-03-15
RU2010117173A (ru) 2011-11-10
PT2197456E (pt) 2011-05-18
CA2701721C (en) 2016-02-23
CA2701721A1 (en) 2009-04-09
ITRM20070510A1 (it) 2009-04-03
EP2197456B1 (en) 2011-02-23
US20100279981A1 (en) 2010-11-04
KR101570966B1 (ko) 2015-11-23
ES2361529T3 (es) 2011-06-17
PL2197456T3 (pl) 2012-07-31
US8455462B2 (en) 2013-06-04
MX2010003488A (es) 2010-08-31
JP2010540619A (ja) 2010-12-24
WO2009044423A1 (en) 2009-04-09
JP5542674B2 (ja) 2014-07-09

Similar Documents

Publication Publication Date Title
ATE499106T1 (de) Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure
MY210233A (en) Methods and compositions for topical delivery
JP2010540619A5 (enExample)
BRPI0519508A2 (pt) análogos de aminopirazina para tratamento de glaucoma e outras doenças ou condições mediadas por rho cinase
IN2012DN03632A (enExample)
MY159463A (en) Method and composition for treating ocular hypertension and glaucoma
MX2010003774A (es) Formulaciones oftalmicas acuosas.
EA200801839A1 (ru) Иммуногенная композиция
ATE454908T1 (de) In situ okklusionszusammensetzungen mit natürlichen biologisch abbaubaren polysacchariden
MX2009004362A (es) Compuestos mediante benzoilo amino heterociclilo util en el tratamiento de una enfermedad a traves de glk.
MX2009004467A (es) Compuestos benzoilo amino heterociclilo como activadores de la glucoquinasa (glk).
ATE554747T1 (de) Hochviskose makromolekulare zusammensetzungen zur behandlung von augenerkrankungen
TW200733964A (en) (Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating rho kinase-mediated diseases and conditions
DK0892636T3 (da) Med tamarindfrøpolysaccharider fortykkede ophthalmiske opløsninger
EA200800564A1 (ru) Производные ксантина как селективные агонисты нм74а
BR112012007114A2 (pt) métodos e composições para tratamento da fibrose ocular
ATE479453T1 (de) Polymermischungen von anionischen und kationischen polysacchariden und verwendung davon
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
MY150250A (en) Ketorolac tromethamine compositions for treating or preventing ocular pain
BR112014027582A8 (pt) composições oftalmicas com proteção e retenção de dessecação aperfeiçoada
HRP20231090T1 (hr) Pripravci i metode sinergističkog tretmana glikokaliksa
MX2019009711A (es) Mejoras en o con respecto a compuestos organicos.
CY1110644T1 (el) 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις
EA200802307A1 (ru) Бинарные смеси гиалуроновой кислоты и их терапевтическое применение
WO2021074649A3 (en) Methods of promoting scfa production by gut microbiota